Estrace vs. Vivelle-Dot
See how Estrace and Vivelle-Dot compare on approved uses, dosing, side effects, and cost.
Key Takeaways
Estrace is a daily oral tablet while Vivelle-Dot is a twice-weekly skin patch, so the main practical difference is how each one is taken.
Both treat menopausal hot flashes, vaginal dryness, and help prevent osteoporosis, but only Estrace is approved for palliative treatment of certain breast and prostate cancers.
Transdermal estrogen like Vivelle-Dot skips first-pass liver metabolism, which may carry a lower clotting risk than oral estrogen like Estrace.
Estrace vs. Vivelle-Dot Drug Summary
Estrace
Estrace is an oral estrogen (estradiol) tablet approved to treat moderate to severe hot flashes and vaginal dryness of menopause, as well as low estrogen from ovarian failure or hypogonadism. It is taken by mouth one to three times a day depending on the dose and indication, and it is also used to help prevent osteoporosis and, in some cases, to palliate certain breast and prostate cancers.
Vivelle-Dot
Vivelle-Dot is a transdermal estrogen (estradiol) patch approved to treat the same core menopausal symptoms, hot flashes and vaginal dryness, along with low estrogen from ovarian failure or hypogonadism. It is applied to the lower abdomen or buttocks and replaced twice a week, and it is also used to help prevent postmenopausal osteoporosis.
Estrace vs. Vivelle-Dot Side Effects
Estrace
Vivelle-Dot
Estrace vs. Vivelle-Dot Dosage
Estrace
Vivelle-Dot
| STAGE | DOSE | WHEN |
| Starting dose | 0.5 mg daily | At the start |
| Maximum dose | 10 mg three times daily | If needed |
| Dose changes | 4 increases | As tolerated |
| STAGE | DOSE | WHEN |
| Starting dose | 0.025 mg/day patch | At the start |
| Maximum dose | 0.1 mg/day patch | If needed |
| Dose changes | 4 increases | As tolerated |
Estrace
| STAGE | DOSE | WHEN |
| Starting dose | 0.5 mg daily | At the start |
| Maximum dose | 10 mg three times daily | If needed |
| Dose changes | 4 increases | As tolerated |
Vivelle-Dot
| STAGE | DOSE | WHEN |
| Starting dose | 0.025 mg/day patch | At the start |
| Maximum dose | 0.1 mg/day patch | If needed |
| Dose changes | 4 increases | As tolerated |
Estrace vs. Vivelle-Dot Indications
Estrace
Estrace is an oral estrogen tablet approved to treat moderate to severe hot flashes and vaginal dryness of menopause, along with low estrogen from ovarian failure or hypogonadism. It is also approved to help prevent osteoporosis and, less commonly, as palliative therapy for certain breast and prostate cancers.
Moderate to severe hot flashes and night sweats of menopause
Vaginal dryness and irritation from menopause (vulvovaginal atrophy)
Low estrogen from ovarian failure, hypogonadism, or ovary removal
Prevention of bone loss (osteoporosis) after menopause
Vivelle-Dot
Vivelle-Dot is an estradiol skin patch approved to treat the same moderate to severe hot flashes and vaginal dryness of menopause, along with low estrogen from ovarian failure or hypogonadism. It is also approved to help prevent osteoporosis after menopause, applied twice weekly to the skin.
Moderate to severe hot flashes and night sweats of menopause
Vaginal dryness and irritation from menopause (vulvovaginal atrophy)
Low estrogen from ovarian failure, hypogonadism, or ovary removal
Prevention of bone loss (osteoporosis) after menopause
Estrace vs. Vivelle-Dot Pros and Cons
Estrace
Estrace is an oral estradiol tablet with decades of clinical use since its 1975 FDA approval, and generic versions are widely available. Like all systemic estrogens, it carries boxed warnings for blood clots, stroke, and endometrial cancer risk in women with a uterus.
Pros
Taken by mouth, no patch site care or skin rotation needed
Available in multiple tablet strengths for flexible dosing
Decades of clinical use since its 1975 FDA approval
Roughly $8 to $65 per month without insurance, often generic
Cons
Requires daily dosing, and some regimens need multiple doses a day
Oral estrogen passes through the liver, a higher clotting risk than patches
The 2 mg tablet contains a dye that can trigger allergic reactions
Vivelle-Dot
Vivelle-Dot delivers estradiol through a twice-weekly skin patch, which some patients find more convenient than a daily pill. Like all systemic estrogens, it carries boxed warnings for blood clots, stroke, and endometrial cancer risk in women with a uterus.
Pros
Only applied twice a week, no daily pill to remember
Transdermal delivery skips the liver, a lower clotting risk than pills
Five patch strengths allow fine-tuned dose adjustments
Can shower, swim, or exercise without the patch coming off
Cons
Can cause skin redness or irritation at the patch site
Not approved for palliative treatment of breast or prostate cancer, unlike Estrace
Brand-name patches often cost $150 to $450 per month without insurance
Common Symptoms and Related Diseases You Can Explore
Explore a range of common symptoms the Doctronic Symptom Checker can help you understand.